{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:38:49Z","timestamp":1787960329992,"version":"build-2784847793"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1124\/jpet.104.074740","type":"journal-article","created":{"date-parts":[[2005,1,15]],"date-time":"2005-01-15T01:38:26Z","timestamp":1105753106000},"page":"710-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Evaluation of Tamsulosin and Alfuzosin Activity in the Rat Vas Deferens: Relevance to Ejaculation Delays"],"prefix":"10.1016","volume":"312","author":[{"given":"Simone","family":"Tambaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Ruiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Mongeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Pani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.074740_bib1","doi-asserted-by":"crossref","unstructured":"Aboud R, Shafii M, and Docherty JR (1993) Investigation of the subtypes of alpha 1-adrenoreceptor mediating contractions of rat aorta, vas deferens and spleen. Br J Pharmacol 109: 80-87.","DOI":"10.1111\/j.1476-5381.1993.tb13534.x"},{"key":"10.1124\/jpet.104.074740_bib2","doi-asserted-by":"crossref","unstructured":"Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14: 48-58.","DOI":"10.1111\/j.1476-5381.1959.tb00928.x"},{"key":"10.1124\/jpet.104.074740_bib3","doi-asserted-by":"crossref","unstructured":"Boselli C, Bianchi L, Barbieri A, and Grana E (1998) Effect of calcium antagonists on the response to NA in the whole and bisected rat vas deferens. J Auton Pharmacol 18: 297-306.","DOI":"10.1046\/j.1365-2680.1998.18598.x"},{"key":"10.1124\/jpet.104.074740_bib4","doi-asserted-by":"crossref","unstructured":"Brown DA, Docherty JR, French AM, MacDonald A, McGrath JC, and Scott NC (1983) Separation of adrenergic and non-adrenergic contractions to field stimulation in rat vas deferens. Br J Pharmacol 79: 379-393.","DOI":"10.1111\/j.1476-5381.1983.tb11010.x"},{"key":"10.1124\/jpet.104.074740_bib5","doi-asserted-by":"crossref","unstructured":"Burt RP, Chapple CR, and Marshall I (1995) Evidence for a functional alpha 1A-(alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenoceptor mediating contraction of the rat spleen. Br J Pharmacol 115: 467-475.","DOI":"10.1111\/j.1476-5381.1995.tb16356.x"},{"key":"10.1124\/jpet.104.074740_bib6","doi-asserted-by":"crossref","unstructured":"Burt RP, Christopher R, Chapple CR, and Marshall I (1998) Alpha 1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC. Br J Pharmacol 123: 317-325.","DOI":"10.1038\/sj.bjp.0701588"},{"key":"10.1124\/jpet.104.074740_bib7","doi-asserted-by":"crossref","unstructured":"Caine M, Pfau A, and Perleberg S (1976) The use of alpha-adrenergic blockers in benign prostatic obstruction. Br J Urol 48: 255-263.","DOI":"10.1111\/j.1464-410X.1976.tb10214.x"},{"key":"10.1124\/jpet.104.074740_bib8","doi-asserted-by":"crossref","unstructured":"Carbone DJ Jr and Hodges S (2003) Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life. Int J Impot Res 15: 299-306.","DOI":"10.1038\/sj.ijir.3901017"},{"key":"10.1124\/jpet.104.074740_bib9","doi-asserted-by":"crossref","unstructured":"Foglar R, Shibata K, Horie K, Hirasawa A, and Tsujimoto G (1995) Use of recombinant \u03b11-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur J Pharmacol 288: 201-207.","DOI":"10.1016\/0922-4106(95)90195-7"},{"key":"10.1124\/jpet.104.074740_bib10","doi-asserted-by":"crossref","unstructured":"Forray C, Bard JA, Wetzel JM, Chiu G, Shapiro E, Tang R, Lepor H, Hartig PR, Weinshank RL, Branchek TA, et al. (1994) The \u03b11-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human \u03b11c subtype. Mol Pharmacol 45: 703-708.","DOI":"10.1016\/S0026-895X(25)10156-9"},{"key":"10.1124\/jpet.104.074740_bib11","doi-asserted-by":"crossref","unstructured":"Giuliano F, Bernabe J, Droupy S, Alexandre L, and Allard J (2004) A comparison of the effects of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rat. BJU Int 93: 605-608.","DOI":"10.1111\/j.1464-410X.2003.04674.x"},{"key":"10.1124\/jpet.104.074740_bib12","doi-asserted-by":"crossref","unstructured":"Han C, Abel PW, and Minneman KP (1987) \u03b11-Adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle. Nature (Lond) 329: 333-335.","DOI":"10.1038\/329333a0"},{"key":"10.1124\/jpet.104.074740_bib13","doi-asserted-by":"crossref","unstructured":"Hanft G and Gross G (1989) Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br J Pharmacol 97: 691-700.","DOI":"10.1111\/j.1476-5381.1989.tb12005.x"},{"key":"10.1124\/jpet.104.074740_bib14","doi-asserted-by":"crossref","unstructured":"Hieble JP, Bylund DB, Clarke DE, Eikenburg DC, Langer SZ, Lefkowitz RJ, Minneman KP, and Ruffolo RR Jr (1995) International Union of Pharmacology. X. Recommendation for nomenclature of \u03b11-adrenoceptors: consensus update. Pharmacol Rev 47: 267-270.","DOI":"10.1016\/S0031-6997(25)06845-0"},{"key":"10.1124\/jpet.104.074740_bib15","doi-asserted-by":"crossref","unstructured":"Honner V and Docherty JR (1999) Investigation of the subtypes of \u03b11-adrenoceptor mediating contractions of rat vas deferens. Br J Pharmacol 128: 1323-1331.","DOI":"10.1038\/sj.bjp.0702913"},{"key":"10.1124\/jpet.104.074740_bib16","doi-asserted-by":"crossref","unstructured":"Kenny BA, Miller AM, Williamson IJR, O\u2019Connell J, Chalmers DH, and Naylor AM (1996) Evaluation of the pharmacological selectivity profile of \u03b11 adrenoceptor antagonists at prostatic \u03b11 adrenoceptors: binding, functional and in vivo studies. Br J Pharmacol 118: 871-878.","DOI":"10.1111\/j.1476-5381.1996.tb15480.x"},{"key":"10.1124\/jpet.104.074740_bib17","doi-asserted-by":"crossref","unstructured":"Lef\u00e8vre-Borg F, O\u2019Connor SE, Schoemaker H, Hicks PE, Lechaire J, Gautier E, Pierre F, Pimoule C, Manoury P, and Langer SZ (1993) Alfuzosin, a selective \u03b11-adrenoceptor antagonist in the lower urinary tract. Br J Pharmacol 109: 1282-1289.","DOI":"10.1111\/j.1476-5381.1993.tb13762.x"},{"key":"10.1124\/jpet.104.074740_bib18","doi-asserted-by":"crossref","unstructured":"Leonardi A, Hieble JP, Guarneri L, Naselsky DP, Poggesi E, Sironi G, Sulpizio AC, and Testa R (1997) Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15\/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I. J Pharmacol Exp Ther 281: 1272-1283.","DOI":"10.1016\/S0022-3565(24)36701-1"},{"key":"10.1124\/jpet.104.074740_bib19","doi-asserted-by":"crossref","unstructured":"Lepor H (1993) Medical therapy for benign prostatic hyperplasia. Urology 42: 483-501.","DOI":"10.1016\/0090-4295(93)90258-C"},{"key":"10.1124\/jpet.104.074740_bib20","doi-asserted-by":"crossref","unstructured":"Lepor H (1998) Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group. Urology 51: 892-900.","DOI":"10.1016\/S0090-4295(98)00126-5"},{"key":"10.1124\/jpet.104.074740_bib21","doi-asserted-by":"crossref","unstructured":"Lepor H, Tang R, Kobayashi S, Shapiro E, Forray C, Wetzel JM, and Gluchowski C (1995) Localization of the alpha 1A-adrenoceptor in the human prostate. J Urol 154: 2096-2099.","DOI":"10.1016\/S0022-5347(01)66704-1"},{"key":"10.1124\/jpet.104.074740_bib22","doi-asserted-by":"crossref","unstructured":"Matsuki N, Higo K, Saito H, and Nakazawa K (1996) Regional difference in sympathetic neurotransmitter- and Ca2+ channel-mediated responses in rat vas deferens. Gen Pharmacol 27: 689-693.","DOI":"10.1016\/0306-3623(95)02085-3"},{"key":"10.1124\/jpet.104.074740_bib23","doi-asserted-by":"crossref","unstructured":"McKeage K and Plosker GL (2002) Alfuzosin: a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia. Drugs 62: 633-653.","DOI":"10.2165\/00003495-200262040-00009"},{"key":"10.1124\/jpet.104.074740_bib24","doi-asserted-by":"crossref","unstructured":"Michel MC, Gr\u00fcbbel B, Taguchi K, Verf\u00fcrth F, Otto T, and Kr\u00f6pfl D (1996) Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned \u03b11-adrenoceptor subtypes and in human prostate. J Auton Pharmacol 16: 21-28.","DOI":"10.1111\/j.1474-8673.1996.tb00352.x"},{"key":"10.1124\/jpet.104.074740_bib25","doi-asserted-by":"crossref","unstructured":"Michel MC and Insel PA (1994) Comparison of cloned and pharmacologically defined rat tissue alpha1-adrenoceptor subtypes. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 350: 136-142.","DOI":"10.1007\/BF00241087"},{"key":"10.1124\/jpet.104.074740_bib26","doi-asserted-by":"crossref","unstructured":"Michel MC, Kenny B, and Schwinn DA (1995) Classification of \u03b11-adrenoceptor subtypes. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 352: 1-10.","DOI":"10.1007\/BF00169183"},{"key":"10.1124\/jpet.104.074740_bib27","doi-asserted-by":"crossref","unstructured":"Monda JM and Oesterling JE (1993) Medical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists. Mayo Clin Proc 68: 670-679.","DOI":"10.1016\/S0025-6196(12)60603-X"},{"key":"10.1124\/jpet.104.074740_bib28","doi-asserted-by":"crossref","unstructured":"Moritoki H, Iwamoto T, Kanaya J, Maeshiba Y, Ishida Y, and Fukuda H (1987) Verapamil enhances the non-adrenergic twitch response of rat vas deferens. Eur J Pharmacol 140: 75-83.","DOI":"10.1016\/0014-2999(87)90636-4"},{"key":"10.1124\/jpet.104.074740_bib29","doi-asserted-by":"crossref","unstructured":"Nasu K, Moriyama N, Fukasawa R, Tsujimoto G, Tanaka T, Yano J, and Kawabe K (1998) Quantification and distribution of \u03b11-adrenoceptor subtype mRNAs in human proximal urethra. Br J Pharmacol 123: 1289-1293.","DOI":"10.1038\/sj.bjp.0701731"},{"key":"10.1124\/jpet.104.074740_bib30","doi-asserted-by":"crossref","unstructured":"Noble AJ, Chess-Williams R, Couldwell C, Furukawa K, Uchyiuma T, Korstanje C, and Chapple CR (1997) The effects of tamsulosin, a high affinity antagonist at functional \u03b11A- and \u03b11D-adrenoceptor subtypes. Br J Pharmacol 120: 231-238.","DOI":"10.1038\/sj.bjp.0700907"},{"key":"10.1124\/jpet.104.074740_bib31","doi-asserted-by":"crossref","unstructured":"Price DT, Schwinn DA, Lomasney JW, Allen LF, Caron MG, and Lefkowitz RJ (1993) Identification, quantification and localization of mRNA for three distinct alpha-1-adrenergic receptor subtypes in human prostate. J Urol 150: 546-551.","DOI":"10.1016\/S0022-5347(17)35544-1"},{"key":"10.1124\/jpet.104.074740_bib32","doi-asserted-by":"crossref","unstructured":"Richardson CD, Donatucci CF, Page SO, Wilson KH, and Schwinn DA (1997) Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned \u03b11-adrenergic receptor subtypes. Prostate 33: 55-59.","DOI":"10.1002\/(SICI)1097-0045(19970915)33:1<55::AID-PROS9>3.3.CO;2-S"},{"key":"10.1124\/jpet.104.074740_bib33","doi-asserted-by":"crossref","unstructured":"Sneddon P and Machaly M (1992) Regional variation in purinergic and adrenergic responses in isolated vas deferens of rat, rabbit and guinea-pig. J Auton Pharmacol 12: 421-428.","DOI":"10.1111\/j.1474-8673.1992.tb00390.x"},{"key":"10.1124\/jpet.104.074740_bib34","doi-asserted-by":"crossref","unstructured":"Vizi ES and Sperl\u00e1gh B (1999) Receptor- and carrier-mediated release of ATP of postsynaptic origin: cascade transmission. Prog Brain Res 120: 159-169.","DOI":"10.1016\/S0079-6123(08)63553-0"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524318038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524318038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.074740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:18:28Z","timestamp":1739999908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524318038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0022356524318038"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.074740","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Tamsulosin and Alfuzosin Activity in the Rat Vas Deferens: Relevance to Ejaculation Delays","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.074740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}